Objective: To investigate the effects of rosiglitazone (RSG) on insulin sensitivity and regional adiposity (including intrahepatic fat) in patients with type 2 diabetes. Research Methods and Procedures: We examined the effect of RSG (8 mg/day, 2 divided doses) compared with placebo on insulin sensitivity and body composition in 33 type 2 diabetic patients. Measurements of insulin sensitivity (euglycemic hyperinsulinemic clamp), body fat (abdominal magnetic resonance imaging and DXA), and liver fat (magnetic resonance spectroscopy) were taken at baseline and repeated after 16 weeks of treatment. Results: There was a significant improvement in glycemic control (glycosylated hemoglobin -0.7 +/- 0.7%, p less than or equal to 0.05) and an 86% in...
BACKGROUND: Few studies have directly compared rosiglitazone and metformin effects on adipocytokin...
BACKGROUND: Few studies have directly compared rosiglitazone and metformin effects on adipocytokin...
Objective: The aim of this study was to determine whether reduction of hyperinsulinemia with rosigli...
AIMS: We examined the effect of rosiglitazone on insulin sensitivity, abdominal fat and mid-thigh in...
OBJECTIVE: The goal was to investigate the interrelationships between the hypoglycemic effects of ro...
AIMS/HYPOTHESIS: We investigated the effects of rosiglitazone on NEFA and triglyceride metabolism in...
Context: Wehave shown that rosiglitazone increases whole-body and adipose tissue insulin sensitivity...
AIMS/HYPOTHESIS: We investigated the effects of rosiglitazone on NEFA and triglyceride metabolism in...
Aims/Hypothesis: Diabetic hyperglycemia results from insulin resistance of peripheral tissues and gl...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
BACKGROUND: Few studies have directly compared rosiglitazone and metformin effects on adipocytokin...
BACKGROUND: Few studies have directly compared rosiglitazone and metformin effects on adipocytokin...
BACKGROUND: Few studies have directly compared rosiglitazone and metformin effects on adipocytokin...
Objective: The aim of this study was to determine whether reduction of hyperinsulinemia with rosigli...
AIMS: We examined the effect of rosiglitazone on insulin sensitivity, abdominal fat and mid-thigh in...
OBJECTIVE: The goal was to investigate the interrelationships between the hypoglycemic effects of ro...
AIMS/HYPOTHESIS: We investigated the effects of rosiglitazone on NEFA and triglyceride metabolism in...
Context: Wehave shown that rosiglitazone increases whole-body and adipose tissue insulin sensitivity...
AIMS/HYPOTHESIS: We investigated the effects of rosiglitazone on NEFA and triglyceride metabolism in...
Aims/Hypothesis: Diabetic hyperglycemia results from insulin resistance of peripheral tissues and gl...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients wit...
BACKGROUND: Few studies have directly compared rosiglitazone and metformin effects on adipocytokin...
BACKGROUND: Few studies have directly compared rosiglitazone and metformin effects on adipocytokin...
BACKGROUND: Few studies have directly compared rosiglitazone and metformin effects on adipocytokin...
Objective: The aim of this study was to determine whether reduction of hyperinsulinemia with rosigli...